Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Novo Nordisk

Diabetes Epidemic Makes this Stock a Strong Buy

Diabetes is a growing concern as more of the globe becomes modernized and with that is eating a diet that too often is a road to diabetes. Gladly there are drug companies at the forefront of this movement to stem the tide like Novo Nordisk (NVO) making it a very…

StockNews.com

Semaglutide: beware of buying the weight-loss drug online

A few years ago, celebrity weight-control practices were out of most people’s reach. Live-in chefs and personal trainers, not to mention elaborate surgical procedures like the Brazilian butt lift, were not real options for most. But with the advent of drugs such as semaglutide, it seems that anyone can go…

The Conversation

Wegovy is "not a magic bullet" - 3 doctors reveal what you need to know as the drug is set to be prescribed in the UK

As Wegovy is set to be available on prescription in the UK, we asked doctors what they think of the controversial weight loss injections

Woman & Home

From analysis to the latest developments in health,
read the most diverse news in one place.

Tilray Brands (TLRY) vs. Novo Nordisk (NVO): Which Pharma Stock Should You Buy?

The pharmaceutical sector performs relatively well during economic uncertainties due to inelastic demand for its products and services. While prominent players Tilray Brands (TLRY) and Novo Nordisk (NVO) should benefit, which stock is the better buy now? Read more to find out.

StockNews.com

As Serena Williams Opens Up About Her Ozempic Fat Loss Journey – We Spoke to Top Experts About the Repercussions

The tennis champion shared her decision to take this step was multi-faceted and motivated by a desire to "be at a healthy place."

Marie Claire

How the new 'game-changing' weight loss drug works, who is eligible and when it will be available in UK

The National Institute for Health and Care Excellence gave approval for the use of appetite suppressant Wegovy (semaglutide) earlier this year - here are more details about it

Chronicle Live

How does Wegovy work? The ‘game changing’ weight loss drug beloved by Hollywood

Ministers have announced plans which could see tens of thousands given access to new weight-loss drug

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Why You Should Go Overweight On Novo Nordisk Stock

Novo Nordisk is already the global kingpin in diabetes treatments, with about 30% of the $50+ billion global diabetes market and around half of the $20 billion insulin therapy market. Now, it is becoming a powerhouse in weight-loss drugs, thanks to its Wegovy drug.

Barchart

Watch out for Ozempic copycats containing unauthorized active ingredients, FDA warns

Some compounding pharmacies are using unauthorized active ingredients to make copycat versions of Ozempic and Wegovy.

LiveScience

Friday briefing: Are appetite-suppressing drugs really a fast track to weight loss?

In today’s newsletter: Semaglutide has won endorsements from celebrities and expert drugs advisers and has gone viral on TikTok. But don’t expect a quick fix

The Guardian - UK

Families scramble to find growth hormone drug as shortage drags on

Children who need growth hormone to achieve their full stature are having trouble getting the medicine. A shortage has stretched months longer than expected and could last the rest of the year.

WEKU

WHO issues warning on weight loss drugs

Balanced diet and exercise remain key to losing weight, health body says

The Independent UK

Exclusive-Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review

New highly-effective weight loss drugs such as Novo Nordisk's Wegovy are not a “silver bullet” for addressing the rapid rise in global obesity rates, the World Health Organization’s nutrition chief told Reuters, as the agency conducts its first review of obesity management guidelines in more than 20 years.

Reuters

What's behind shortages of Adderall, Ozempic and other meds?

Drug shortages are growing in the United States, and experts see no clear path to resolving them

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Can drugs fix the UK’s adolescent obesity crisis?

A powerful new weight-loss medication may be approved for those aged 12 to 17. But healthcare professionals fear it ignores the underlying socioeconomic causes

The Guardian - UK

Children could be prescribed weight-loss jabs on the NHS

Department of Health asks watchdog to assess effectiveness of giving semaglutide to obese youngsters aged 12 to 17

Chronicle Live

Doctors issue urgent warning over diabetes drug Ozempic being sold on Facebook Marketplace

The alert comes after an increased number of social media posts, in which users are marketing the drug as a rapid weight loss solution

Salon

Social Media adds to weight loss craze

GLP-1 agonists are a class of weight loss drug that is going viral on social media — but misinformation is rife

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

A ‘skinny jab’ is no quick fix for obesity – and no excuse to let junk food companies off the hook

Britain should be taxing unhealthy food and clamping down on marketing, says Sarah Boseley, the Guardian’s former health editor

Tribune News Service

Social media is fueling enthusiasm for new weight loss drugs. Are regulators watching?

Suzette Zuena is her own best advertisement for weight loss.

Chicago Sun-Times

Experts warn new weight loss medications carry long-term concerns

Some doctors, psychologists and eating disorder experts worry these new medications, originally developed to treat diabetes, could become a problem long-term.

Marie Claire

So, is Wegovy the same as Ozempic? Your need-to-knows about the controversial over-the-counter weight loss drugs

Two experts explain.

The Guardian - UK

Revealed: maker of Wegovy ‘skinny jab’ is funding NHS weight-loss services

Critics fear conflict of interest as Novo Nordisk helps medics ‘reduce unnecessary barriers’ to treatment for obesity

Reuters

EU backs use of Novo Nordisk's weight loss drug in adolescents

The European Medicines Agency said on Friday its committee has recommended expanding the use of Danish drugmaker Novo Nordisk's weight loss drug in adolescents aged 12 years and older.

Barchart

How Investors are Capitalizing on the Ozempic and Wegovy Craze

Ozempic and Wegovy started as injectable diabetes treatments. But now, these “appetite suppressants” are being touted as miracle weight loss drugs.

1 … 23 24 25 26

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations